| Noel Susan Baker, MD | |
|
910 E Houston St Ste 330, Tyler, TX 75702-8368 | |
| (903) 510-8848 | |
| Not Available |
| Full Name | Noel Susan Baker |
|---|---|
| Gender | Female |
| Speciality | Neurology |
| Experience | 38 Years |
| Location | 910 E Houston St Ste 330, Tyler, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386605590 | NPI | - | NPPES |
| 8W6743 | Other | TX | BCBS |
| 752616977052 | Other | TX | TRICARE |
| 284588501 | Medicaid | TX | |
| 752616977095 | Other | TX | TRICARE |
| 106201002 | Medicaid | TX | |
| 752616977103 | Other | TX | TRICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | K5791 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Christus Mother Frances Hospital | Tyler, TX | Hospital |
| Christus Good Shepherd Medical Center | Longview, TX | Hospital |
| Christus Mother Frances Hospital Sulphur Springs | Sulphur springs, TX | Hospital |
| Christus St Michael Health System | Texarkana, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Christus Trinity Clinic | 3072426741 | 1227 |
News Archive
Lannett Company, Inc. today announced that it has received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Ondansetron Injection USP, 2 mg/mL, Multi-Dose Vials. Ondansetron Injection USP, 2 mg/mL is the generic equivalent of GlaxoSmithKline's Zofran® Injection, 2 mg/mL. For the 12 months ending December 2009 U.S. sales of Ondansetron Injection USP, 2 mg/mL were approximately $58 million at Average Wholesale Price (AWP). A launch date for the product has not yet been set.
Patients who are undernourished when they enter the hospital with an acute ischemic stroke the most common type of stroke, in which blood flow to the brain is blocked are likely to remain undernourished in the hospital and may have worse clinical outcomes, according to a report in the January issue of Archives of Neurology.
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
The number of U.S. residents with Alzheimer's disease is increasing annually, putting more pressure on the health care system, according to a report issued on Tuesday by the Alzheimer's Association, USA Today reports (Brophy Marcus, USA Today, 3/24).
› Verified 9 days ago
| Entity Name | Christus Trinity Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285684225 PECOS PAC ID: 3072426741 Enrollment ID: O20031204001091 |
News Archive
Lannett Company, Inc. today announced that it has received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Ondansetron Injection USP, 2 mg/mL, Multi-Dose Vials. Ondansetron Injection USP, 2 mg/mL is the generic equivalent of GlaxoSmithKline's Zofran® Injection, 2 mg/mL. For the 12 months ending December 2009 U.S. sales of Ondansetron Injection USP, 2 mg/mL were approximately $58 million at Average Wholesale Price (AWP). A launch date for the product has not yet been set.
Patients who are undernourished when they enter the hospital with an acute ischemic stroke the most common type of stroke, in which blood flow to the brain is blocked are likely to remain undernourished in the hospital and may have worse clinical outcomes, according to a report in the January issue of Archives of Neurology.
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
The number of U.S. residents with Alzheimer's disease is increasing annually, putting more pressure on the health care system, according to a report issued on Tuesday by the Alzheimer's Association, USA Today reports (Brophy Marcus, USA Today, 3/24).
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Noel Susan Baker, MD Po Box 846098, Dallas, TX 75284-6098 Ph: (903) 324-6450 | Noel Susan Baker, MD 910 E Houston St Ste 330, Tyler, TX 75702-8368 Ph: (903) 510-8848 |
News Archive
Lannett Company, Inc. today announced that it has received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Ondansetron Injection USP, 2 mg/mL, Multi-Dose Vials. Ondansetron Injection USP, 2 mg/mL is the generic equivalent of GlaxoSmithKline's Zofran® Injection, 2 mg/mL. For the 12 months ending December 2009 U.S. sales of Ondansetron Injection USP, 2 mg/mL were approximately $58 million at Average Wholesale Price (AWP). A launch date for the product has not yet been set.
Patients who are undernourished when they enter the hospital with an acute ischemic stroke the most common type of stroke, in which blood flow to the brain is blocked are likely to remain undernourished in the hospital and may have worse clinical outcomes, according to a report in the January issue of Archives of Neurology.
People in their 60s and 70s are now over five times more likely to be diagnosed with malignant melanoma - the deadliest type of skin cancer - than their parents would have been 30 years ago, reveal new Cancer Research UK statistics1 to launch the 2010 SunSmart campaign today (Thursday).
The number of U.S. residents with Alzheimer's disease is increasing annually, putting more pressure on the health care system, according to a report issued on Tuesday by the Alzheimer's Association, USA Today reports (Brophy Marcus, USA Today, 3/24).
› Verified 9 days ago
Brandon Riley, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 11937 Us Highway 271, Tyler, TX 75708 Phone: 903-877-7777 | |
Dr. Joseph Soliman Wassef, M.D., P.C. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2010 Sybil Ln Ste 150, Tyler, TX 75703 Phone: 903-504-5459 Fax: 903-504-5460 | |
Richard D Tyer, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 312 E 5th St, Tyler, TX 75701 Phone: 903-595-6789 Fax: 903-595-6973 | |
Igal Tarash, DO MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 11937 Us Highway 271, Tyler, TX 75708 Phone: 903-877-7168 Fax: 903-877-8356 | |
Dr. Yahyah Smadi, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 11937 Us Highway 271, Tyler, TX 75708 Phone: 903-877-7253 | |
Antoinette Lenton, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 520 Douglas Blvd, Tyler, TX 75702 Phone: 903-593-1721 | |
Dr. Robert Leon Boyne, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 700 Olympic Plaza Cir, Suite 912, Tyler, TX 75701 Phone: 903-596-3808 Fax: 903-596-3815 |